Skip to main content
SpringerLink
Log in

Pregabalin cost effective for chronic cervical pain

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2018 Japanese Yen

Reference

  • Akazawa A, et al. A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan. Journal of Pain Research 2019: 2785-2797, No. 12, 23 Sep 2019. Available from: URL: https://doi.org/10.2147/JPR.S203712

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pregabalin cost effective for chronic cervical pain. PharmacoEcon Outcomes News 838, 24 (2019). https://doi.org/10.1007/s40274-019-6269-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6269-8

Search

Navigation